<scp>CD33</scp> ‐targeting extracellular vesicles deliver antisense oligonucleotides against <scp>FLT3‐ITD</scp> and <scp>miR</scp> ‐125b for specific treatment of acute myeloid leukaemia-Reference-Cited by-同舟云学术

CD33 ‐targeting extracellular vesicles deliver antisense oligonucleotides against FLT3‐ITD and miR ‐125b for specific treatment of acute myeloid leukaemia

Published:2022-07-18 Issue:9 Volume:55 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Proliferation

Author:

Chen Huan¹²³^ORCID,Jayasinghe Migara Kavishka¹²,Yeo Eric Yew Meng¹²,Wu Zhiyuan¹²,Pirisinu Marco³,Usman Waqas Muhammad³,Pham Thach Tuan¹²,Lim Kah Wai⁴,Tran Nhan Van⁴,Leung Anskar Y. H.⁵,Du Xin⁶,Zhang Qiaoxia⁶,Phan Anh Tuân⁴,Le Minh T. N.¹²^ORCID

Affiliation:

1. Department of Pharmacology, Institute for Digital Medicine, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

2. Department of Surgery, Immunology Program, Cancer Program and Nanomedicine Translational Program, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

3. Department of Biomedical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences City University of Hong Kong Kowloon Hong Kong SAR

4. Division of Physics & Applied Physics, School of Physical & Mathematical Sciences Nanyang Technological University Singapore Singapore

5. Department of Medicine, Li Ka Shing Faculty of Medicine, Queen Mary Hospital The University of Hong Kong Pok Fu Lam Hong Kong SAR

6. Department of Hematology and Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen Second People's Hospital The First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine Shenzhen China

Funder

National University of Singapore

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.13255

Reference39 articles.

1. FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?

2. Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment

3. Personalised treatment for acute myeloid Leukaemia—are we there yet?;Leung AY;Hong Kong Med Diary,2014

4. First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the role of long non-coding RNAs in therapeutic resistance in acute myeloid leukemia: New prospects & challenges;Non-coding RNA Research;2024-12

2. IL‐12 minicircle delivery via extracellular vesicles as immunotherapy for bladder cancer;Cell Proliferation;2024-08-28

3. MicroRNA:Siglec crosstalk in cancer progression;Current Opinion in Chemical Biology;2024-08

4. RNAs in the diagnosis and treatment of major diseases;Chinese Science Bulletin;2024-08-01

5. Extracellular vesicle surface display enhances the therapeutic efficacy and safety profile of cancer immunotherapy;Molecular Therapy;2024-07